Kevin Han is a Vice President of Morgan Stanley Expansion Capital. Most recently, Mr. Han led financial operations and strategic planning as Chief Financial Officer at Biological Dynamics. Prior to that, he led investor relations, corporate communications, and sustainability strategies at Bio-Rad Laboratories (NYSE: BIO). He, also, held senior leadership positions as a Portfolio Manager at various asset management firms, Lombard Odier, BlueCrest, and Visium, where he led diligence and investments on numerous IPOs and financings. Mr. Han started his career at Morgan Stanley, and later Goldman Sachs, where his team was named #1 Best Up & Comer by Institutional Investor, covering the medical technology and diagnostics sectors. Mr. Han holds a BS in Business Administration from UNC Kenan-Flagler Business School, was pre-med at the University of North Carolina at Chapel Hill, and has completed Executive Education programs at London Business School and Harvard Business School.
Kevin is a member of the Morgan Stanley Expansion Capital

May not represent all Team Members.

The information on this page is for informational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.

All investing involves risks, including a loss of principal. Alternative investments are speculative and involve a high degree of risk. These investments are designed for investors who understand and are willing to accept these risks. Performance may be volatile, and an investor could lose all or a substantial portion of his or her investment.

Please refer to the strategy detail page for important information on the strategy, including additional risk considerations.


This is a Marketing Communication.

It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.

Privacy & Cookies    •    Your Privacy Choices Your Privacy Choices Icon    •    Terms of Use

©  Morgan Stanley. All rights reserved.